John Patrick Mpindi

818 total citations
17 papers, 513 citations indexed

About

John Patrick Mpindi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, John Patrick Mpindi has authored 17 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in John Patrick Mpindi's work include Prostate Cancer Treatment and Research (4 papers), Cancer-related gene regulation (3 papers) and Gene expression and cancer classification (3 papers). John Patrick Mpindi is often cited by papers focused on Prostate Cancer Treatment and Research (4 papers), Cancer-related gene regulation (3 papers) and Gene expression and cancer classification (3 papers). John Patrick Mpindi collaborates with scholars based in Finland, United States and Norway. John Patrick Mpindi's co-authors include Olli Kallioniemi, Tuomas Mirtti, Kristiina Iljin, Paula Vainio, Henri Sara, Matthias Nees, Santosh Gupta, Kalle Alanen, Juha Rantala and Krister Wennerberg and has published in prestigious journals such as Nature, Blood and PLoS ONE.

In The Last Decade

John Patrick Mpindi

13 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Patrick Mpindi Finland 12 350 162 131 116 48 17 513
Kai Hauser Germany 10 323 0.9× 177 1.1× 161 1.2× 186 1.6× 61 1.3× 29 759
Нуршат Гайфуллин Russia 15 375 1.1× 138 0.9× 185 1.4× 111 1.0× 38 0.8× 36 597
Christopher Moy United States 12 363 1.0× 177 1.1× 161 1.2× 270 2.3× 29 0.6× 17 618
Wayne Blosser United States 15 464 1.3× 95 0.6× 69 0.5× 310 2.7× 27 0.6× 19 637
Jordan F. Hastings Australia 8 256 0.7× 49 0.3× 106 0.8× 127 1.1× 33 0.7× 13 455
Noritaka Tanaka Japan 8 419 1.2× 102 0.6× 98 0.7× 187 1.6× 31 0.6× 28 625
Kartik Subramanian United States 13 328 0.9× 125 0.8× 54 0.4× 153 1.3× 42 0.9× 28 587
Matthew Zubrowski United States 5 506 1.4× 64 0.4× 78 0.6× 266 2.3× 76 1.6× 6 624
Timothy L. Helms United States 5 289 0.8× 125 0.8× 54 0.4× 275 2.4× 51 1.1× 6 452
Tom Januario United States 5 463 1.3× 95 0.6× 126 1.0× 262 2.3× 20 0.4× 8 628

Countries citing papers authored by John Patrick Mpindi

Since Specialization
Citations

This map shows the geographic impact of John Patrick Mpindi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Patrick Mpindi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Patrick Mpindi more than expected).

Fields of papers citing papers by John Patrick Mpindi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Patrick Mpindi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Patrick Mpindi. The network helps show where John Patrick Mpindi may publish in the future.

Co-authorship network of co-authors of John Patrick Mpindi

This figure shows the co-authorship network connecting the top 25 collaborators of John Patrick Mpindi. A scholar is included among the top collaborators of John Patrick Mpindi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Patrick Mpindi. John Patrick Mpindi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Petropoulos, Sophie, Yuanyuan Zhang, Xiaofang Cao, et al.. (2017). The E-cadherin/AmotL2 complex organizes actin filaments required for epithelial hexagonal packing and blastocyst hatching. Scientific Reports. 7(1). 9540–9540. 23 indexed citations
3.
Eide, Christopher A., Swapnil Potdar, Heikki Kuusanmäki, et al.. (2017). Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors. Oncotarget. 8(14). 22606–22615. 15 indexed citations
4.
Kolberg, Matthias, Jarle Bruun, Astrid Murumägi, et al.. (2017). Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors. Molecular Oncology. 11(9). 1156–1171. 16 indexed citations
5.
Mpindi, John Patrick, Bhagwan Yadav, Päivi Östling, et al.. (2016). Consistency in drug response profiling. Nature. 540(7631). E5–E6. 56 indexed citations
6.
Saeed, Khalid, Samuli Eldfors, John Patrick Mpindi, et al.. (2016). Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate Cancer. European Urology. 71(3). 319–327. 72 indexed citations
7.
Saeed, Khalid, Samuli Eldfors, Dmitrii Bychkov, et al.. (2016). Abstract 608: Comprehensive drug testing of patient-derived conditionally reprogrammed cells from castration-resistant prostate cancer. Cancer Research. 76(14_Supplement). 608–608.
8.
Løvf, Marthe, Torfinn Nome, Jarle Bruun, et al.. (2014). A novel transcript, VNN1‐AB, as a biomarker for colorectal cancer. International Journal of Cancer. 135(9). 2077–2084. 14 indexed citations
9.
Pemovska, Tea, Emma Andersson, Perttu Koskenvesa, et al.. (2014). A Profound Biological Difference of Chronic and Blast Phase Chronic Myeloid Leukemia in Ex Vivo Drug Responses. Blood. 124(21). 3139–3139.
10.
Siltanen, Sanna, Daniel Fischer, Tommi Rantapero, et al.. (2013). ARLTS1 and Prostate Cancer Risk - Analysis of Expression and Regulation. PLoS ONE. 8(8). e72040–e72040. 11 indexed citations
11.
Mpindi, John Patrick, Kristiina Iljin, Arto T. Pulliainen, et al.. (2012). Systemic Analysis of Gene Expression Profiles Identifies ErbB3 as a Potential Drug Target in Pediatric Alveolar Rhabdomyosarcoma. PLoS ONE. 7(12). e50819–e50819. 13 indexed citations
12.
Khan, Suleiman A., Ali Faisal, John Patrick Mpindi, et al.. (2012). Comprehensive data-driven analysis of the impact of chemoinformatic structure on the genome-wide biological response profiles of cancer cells to 1159 drugs. BMC Bioinformatics. 13(1). 112–112. 15 indexed citations
13.
Haapa-Paananen, Saija, Santeri Kiviluoto, Marika Waltari, et al.. (2011). HES6 gene is selectively overexpressed in glioma and represents an important transcriptional regulator of glioma proliferation. Oncogene. 31(10). 1299–1310. 27 indexed citations
14.
Mpindi, John Patrick, Henri Sara, Saija Haapa-Paananen, et al.. (2011). GTI: A Novel Algorithm for Identifying Outlier Gene Expression Profiles from Integrated Microarray Datasets. PLoS ONE. 6(2). e17259–e17259. 24 indexed citations
15.
Siltanen, Sanna, Tiina Wahlfors, Martin Schindler, et al.. (2011). Contribution of ARLTS1 Cys148Arg (T442C) Variant with Prostate Cancer Risk and ARLTS1 Function in Prostate Cancer Cells. PLoS ONE. 6(10). e26595–e26595. 8 indexed citations
16.
Mpindi, John Patrick, Henri Sara, Saija Haapa-Paananen, et al.. (2011). Correction: GTI: A Novel Algorithm for Identifying Outlier Gene Expression Profiles from Integrated Microarray Datasets. PLoS ONE. 6(4).
17.
Gupta, Santosh, Kristiina Iljin, Henri Sara, et al.. (2010). FZD4 as a Mediator of ERG Oncogene–Induced WNT Signaling and Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells. Cancer Research. 70(17). 6735–6745. 217 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026